All News

Based on findings from the phase 1/2 BCHILD trial, the FDA approved bosutinib for pediatric chronic myelogenous leukemia.

A government shutdown could impact Medicaid and Medicare in important ways; new Medicare Advantage plans personalize offerings to special populations; nursing homes are still waiting for COVID-19 shots since the US government has stepped back.

Seun Ross, PhD, describes the goals Independence Blue Cross has for improving maternal health, diabetes, cardiovascular conditions, and behavioral health.

Natural and synthetic antimicrobial peptides can penetrate deeper skin layers.

As of November 2022, the Pittsburgh Financial Empowerment Center has helped 1227 clients, saved them over $2 million, and helped reduce their debt by almost $3.5 million. Counselor Alicia Donner discusses how the organization not only provides financial assistance but also helps patients cope with unexpected health care expenses.

Lisa Rometty, CEO at Zerigo Health, discusses the challenges and opportunities for growth within the digital health landscape, as well as how Zerigo plans to collaborate with patients and payers to make sure digital health tools are accessible and affordable.

Researchers aimed to identify the characteristics, treatment pathways, and outcomes associated with epilepsy with eyelid myoclonia (EEM).

In their latest recommendation statement, the US Preventive Services Task Force (USPSTF) recommends blood pressure screening for all pregnant individuals to detect hypertensive disorders.

After FDA approval, XDEMVY is available for prescription nationwide to target Demodex mites, the primary cause of the external eye disease Demodex blepharitis.

Psoriasis increases the risk of cutaneous melanoma, according to the findings of a new study.

Lisa Kottschade, RN, CNP, FAPO, a nurse practitioner at Mayo Clinic, discussed immune-related adverse events and biomarkers in relation to melanoma treatment.

In a real-world setting, artificial intelligence (AI) proved to be effective in screening for referable diabetic retinopathy.

Medicare Advantage and Medicare Part D prescription drug plans will maintain stability in 2024; a report found that women encounter disadvantages in cancer prevention and care; prescriptions for semaglutide, similar drugs surpass 9 million.

Higher neighborhood-level opportunity and social vulnerability measures were associated with pediatric asthma incidence, a new study has found.

Women with ovarian, breast, skin, and uterine cancers were found to have significantly higher levels of per- and polyfluoroalkyl substances (PFAS), phenols, and parabens in their bodies.

The number one ingredient that an oncology-based alternative payment model needs to succeed is collaboration, explained Nicolas Ferreyros, managing director of policy, advocacy, and communications, Community Oncology Alliance (COA).

Data from fee-for-service Medicare claims that were linked to the Surveillance, Epidemiology, and End Results program were used for this retrospective cohort analysis among women 70 years and older.

To reduce the global burden of respiratory diseases and tackle inequalities, the Forum of International Respiratory Studies and the American Thoracic Society suggested improving access to preventive services, inhaler therapies, and effective pneumonia vaccines.

Transmasculine individuals found mobile apps such as Transpire to be beneficial in increasing their access to information on sexual health.

A new study confirmed the validity of a blood test that can diagnose patients with GLUT1 deficiency syndrome, a treatable neurometabolic disease that causes a wide range of neurologic symptoms in children and adults, including seizures.

Employees want to know that their employers have a vested interest in their health, Vikki Walton, MBA, health equity leader at Mercer, explains.

Although nofazinlimab was well tolerated and showed antitumor activity in many tumor types, no response was found when combined with regorafenib to treat metastatic colorectal cancer (mCRC).

Michael Petrosky, MD, of the Allegheny Health Network, spoke about how parents can prevent their child from spreading respiratory syncytial virus (RSV) and the availability of monoclonal antibodies for all infants.

Chemotherapy drug shortages put young patients at risk; restrictions and challenges cause concerns of a rise in teen births; at least 28 companies failed to prove sufficient product testing for cough syrups.

Adjuvant therapy, instead of just surgery alone, for early-stage non-small-cell lung cancer (NSCLC) after surgery incurs lower medical costs than surgery alone.

Researchers conducted a cohort study that suggests oral N-acetylglucosamine treatment can hinder neurodegeneration and inflammation associated with multiple sclerosis (MS).

Overactivation of the immune system is a potential serious adverse event (AE) following immune checkpoint inhibition (ICI) treatment for any of several cancers in the first and second line; among these AEs is myasthenia gravis.

Patients with low-grade serous ovarian cancer appear to have worse survival outcomes following treatment with neoadjuvant chemotherapy (NACT).

Researchers found that approximately 17% of respondents with chronic obstructive pulmonary disease (COPD) and no lifetime history of depression developed depression during the early stages of the COVID-19 pandemic, while approximately 52% who had COPD and a history of depression experienced a recurrence of depressive symptoms.

Erin Gillaspie, MD, MPH, FACS, a faculty member of Vanderbilt University Medical Center’s Department of Thoracic Surgery, discussed the role of immunotherapies in lung cancer and how they are used.